Deepak Phadke
24Patents
8h-index
18Co-inventors
72Inventor score
Filing activity: May 12, 1992 → Jun 13, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5302396A | Superior tasting composition having porous particles and the process of preparing such pharmaceutical composition | Human Necessities | 41 | Expired |
| US5738872A | Pharmaceutical composition for piperidinoalkanol compounds | Human Necessities | 15 | Expired |
| US10071977B2 | Highly purifid pharmaceutical grade tasimelteon | Chemistry; Metallurgy | 13 | Active |
| US5855912A | Pharmaceutical compositions for piperidinalkanol compounds | Human Necessities | 11 | Expired |
| US6113942A | Pharmaceutical composition for piperidinoalkanol compounds | Human Necessities | 10 | Expired |
| US10611744B2 | Highly purified pharmaceutical grade tasimelteon | Chemistry; Metallurgy | 10 | Active |
| US10829465B2 | Highly purified pharmaceutical grade tasimelteon | Chemistry; Metallurgy | 10 | Active |
| US5437873A | Superior tasting pharmaceutical composition having porous particles and the process of preparing such pharmaceutical composition | Human Necessities | 9 | Expired |
| US5266334A | Sugar-free dry mix cellulose ether compositions as bulk laxatives | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5932247A | Pharmaceutical composition for piperidinoalkanol compounds | Human Necessities | 8 | Expired |
| US9212129B2 | Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide | Chemistry; Metallurgy | 4 | Active |
| US8129408B2 | Pharmaceutical composition for piperidinoalkanol compounds | Human Necessities | 2 | Active |
| US10874659B2 | Iloperidone metabolite for use in the treatment of psychiatric disorders | Human Necessities | 2 | Active |
| US11566011B2 | Highly purified pharmaceutical grade tasimelteon | Chemistry; Metallurgy | 1 | Active |
| US11760740B2 | Highly purified pharmaceutical grade tasimelteon | Chemistry; Metallurgy | 1 | Active |
| US9617203B2 | Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide | Chemistry; Metallurgy | 1 | Active |
| US11203581B2 | Highly purified pharmaceutical grade tasimelteon | Chemistry; Metallurgy | 1 | Active |
| US8865210B2 | Stable dosage formulations of imidazolylalkyl-pyridines | Human Necessities | 0 | Active |
| US12049457B2 | Highly purified pharmaceutical grade tasimelteon | Chemistry; Metallurgy | 0 | Active |
| US11202770B2 | Liquid tasimelteon formulations and methods of use thereof | Human Necessities | 0 | Active |
| US12304896B2 | Highly purified pharmaceutical grade tasimelteon | Chemistry; Metallurgy | 0 | Active |
| US10233142B2 | Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide | Chemistry; Metallurgy | 0 | Active |
| US11759446B2 | Liquid tasimelteon formulations and methods of use thereof | Human Necessities | 0 | Active |
| US9850199B2 | Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.